TS29205821	drug 73 103	prolyl endopeptidase inhibitor
TS99205821	drug 337 375	prolyl endopeptidase ( PEP ) inhibitor
TS159205821	food 850 854	food
TS129205821	drugEffect 862 877	bioavailability
TS149205821	drugEffect 1290 1333	elevation of plasma cholinesterase activity
TS79205821	drug 1635 1643	JTP-4819
TS19205821	mealTime 1669 1682	fasting state
TS59205821	food 1976 1980	food
T1	drug 31 39	JTP-4819
T2	modeadm 59 65	orally
T3	drug 193 201	JTP-4819
T4	drug 204 303	( - ) - ( 2S ) -1-benzylaminocarbonyl- [ ( 2S ) -2-glycoloylpyrrolidinyl ]-2-pyrrolidinecarboxamide
T5	modeadm 323 329	orally
T6	drug 378 386	JTP-4819
T7	dosage 453 458	30 mg
T8	dosage 471 476	60 mg
T9	dosage 489 495	120 mg
T10	dosage 550 555	60 mg
T11	frequency 556 573	three times daily
T12	frequency 437 449	single doses
T13	duration 606 616	for 7 days
T14	dosage 709 710	3
T15	dosage 713 715	10
T16	dosage 720 725	30 mg
T17	dosage 784 789	60 mg
T18	drug 914 922	JTP-4819
T19	drug 1209 1217	JTP-4819
T20	drug 1368 1376	JTP-4819
R1	has_effect Arg1:T20 Arg2:TS149205821	
T21	dosage 1647 1649	30
T22	dosage 1652 1654	60
T23	dosage 1659 1665	120 mg
T24	drug 2096 2104	JTP-4819
